Ligand Pharmaceuticals
LGND
LGND
352 hedge funds and large institutions have $4.15B invested in Ligand Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 133 increasing their positions, 114 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 347 → 352 (+5)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
0.2% less ownership
Funds ownership: 104.45% → 104.24% (-0.2%)
Holders
352
Holding in Top 10
8
Calls
$8.48M
Puts
$6.95M
Top Buyers
| 1 | +$60.8M | |
| 2 | +$19M | |
| 3 | +$16.7M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$15.2M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.9M |
Top Sellers
| 1 | -$29.8M | |
| 2 | -$21M | |
| 3 | -$18.9M | |
| 4 |
NAMI
Nomura Asset Management International
Philadelphia,
Pennsylvania
|
-$14M |
| 5 |
Goldman Sachs
New York
|
-$9.48M |